- Home
- LVWR vs AKBA Comparison
LVWR vs AKBA Comparison
Compare LVWR & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVWR
- AKBA
- Stock Information
- Founded
- LVWR 2022
- AKBA 2007
- Country
- LVWR United States
- AKBA United States
- Employees
- LVWR N/A
- AKBA N/A
- Industry
- LVWR
- AKBA Biotechnology: Pharmaceutical Preparations
- Sector
- LVWR
- AKBA Health Care
- Exchange
- LVWR Nasdaq
- AKBA Nasdaq
- Market Cap
- LVWR 914.8M
- AKBA 861.7M
- IPO Year
- LVWR N/A
- AKBA 2014
- Fundamental
- Price
- LVWR $4.65
- AKBA $2.88
- Analyst Decision
- LVWR
- AKBA Strong Buy
- Analyst Count
- LVWR 0
- AKBA 5
- Target Price
- LVWR N/A
- AKBA $6.90
- AVG Volume (30 Days)
- LVWR 175.7K
- AKBA 2.9M
- Earning Date
- LVWR 10-23-2025
- AKBA 11-06-2025
- Dividend Yield
- LVWR N/A
- AKBA N/A
- EPS Growth
- LVWR N/A
- AKBA N/A
- EPS
- LVWR N/A
- AKBA N/A
- Revenue
- LVWR $23,822,000.00
- AKBA $203,733,000.00
- Revenue This Year
- LVWR $249.13
- AKBA $43.91
- Revenue Next Year
- LVWR $98.53
- AKBA $32.09
- P/E Ratio
- LVWR N/A
- AKBA N/A
- Revenue Growth
- LVWR N/A
- AKBA 16.75
- 52 Week Low
- LVWR $0.93
- AKBA $1.26
- 52 Week High
- LVWR $9.04
- AKBA $4.08
- Technical
- Relative Strength Index (RSI)
- LVWR 51.94
- AKBA 47.89
- Support Level
- LVWR $4.53
- AKBA $2.83
- Resistance Level
- LVWR $5.49
- AKBA $3.02
- Average True Range (ATR)
- LVWR 0.45
- AKBA 0.12
- MACD
- LVWR -0.05
- AKBA 0.03
- Stochastic Oscillator
- LVWR 17.07
- AKBA 56.94
About LVWR LiveWire Group Inc.
LiveWire Group Inc is an all-electric vehicle company. It sells electric vehicles and related parts and accessories and apparel in the United States and certain international markets. The company's segment includes Electric Motorcycles and STACYC. Electric Motorcycles segment sells electric motorcycles, related parts and accessories and apparel in the United States and certain international markets; STACYC segment sells electric balance bikes for kids, related parts and accessories and apparel in the United States and certain international markets. LiveWire generates revenue from the sale of electric motorcycles, Parts, accessories and apparel. Majority of revenue is from USA.
About AKBA Akebia Therapeutics Inc.
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.